Estée Lauder Companies and Puig have ended merger discussions that could have reshaped the prestige beauty sector, closing a closely watched corporate story before any major agreement was reached. The New York based owner of Clinique, M·A·C, La Mer, Jo Malone London, Tom Ford Beauty, Le Labo, The Ordinary, and other brands confirmed that talks with Spain’s Puig had been terminated. Puig’s portfolio includes Jean Paul Gaultier, Carolina Herrera, Rabanne, Nina Ricci, Dr. Barbara Sturm, and Charlotte Tilbury, giving the possible deal wide attention across beauty, fragrance, skin care, and makeup markets. The companies first confirmed discussions in March 2026 while stressing that no agreement had been reached. That wording left open the possibility that the talks could move forward or end without a signed transaction. By May 2026, the companies had confirmed the talks were over. The possible combination drew attention because it would have connected Estée Lauder’s long standing position in prestige skin care, makeup, and fragrance with Puig’s growing reach in fragrance, fashion linked beauty, and high visibility cosmetics. Public reporting described the proposed transaction as a possible multibillion dollar beauty combination involving brands with strong recognition in department stores, specialty retail, online beauty channels, and luxury shopping. Why the Talks Drew Market Attention The discussions came during a sensitive period for Estée Lauder. The company has been working through a broad reset after pressure in several parts of the beauty market, including weaker demand in certain channels and the need to simplify parts of its operating model. Estée Lauder has outlined a plan called Beauty Reimagined, which is intended to make the company faster and more efficient while supporting its major brands. Public reporting has also noted that the company previously announced workforce reductions as part of a broader effort to improve operations. A Puig transaction